Latest Industry Insights

In recent years, a number of new cell and gene therapies have been developed to treat a variety of indications, including cancer and inherited retinal dystrophies. While these therapies have proven to be beneficial to patients, their scalability and manufacturability are two enduring challenges. Technology Networks spoke to Tara St.Amand, PhD, MBA, director of business technology, bioprocess at Corning to learn more about the key challenges faced when scaling up the manufacturing of cell products.

Technology Networks spoke to Linda De Jesus, senior vice president and chief commercial officer at Azenta Life Sciences to find out more about the announcement and how this will help drive innovation with greater speed and accuracy.

The service will enable oncologists, hematologists and other healthcare professionals to undertake rapid and extensive genomic analysis of cancer samples on an unprecedented scale in the UK.

Technology Networks recently spoke with Dr. Marvin Ouyang, Cyagen’s executive vice president and chief scientific officer, to learn more about humanized mice and the applications they can benefit. In this interview Dr. Ouyang also explains how humanized mice can be generated and highlights some of Cyagen’s capabilities in this area.

Technology Networks spoke with Dr. Bertram Brenig and Illumina to find out more about how studying genetic differences in honey bees will improve breeding programs, and how Illumina will support this research.

Technology Networks recently spoke with Brian Kirk, BioDot’s vice president of business development, to learn more about FISH, its advantages and applications. In this interview, Brian also highlights how new technology is tackling some of the limitations of classical FISH to bring the technique into the 21^st century.

Technology Networks spoke to Guy Levy-Yurista, CEO of Synthace to find out how the new cloud-based solution can support life science research.

Technology Networks spoke to Michael Heltzen, CEO and Dr. Kiana Aran, Chief Scientific Officer of Cardea Bio to find out more about the development of the SNP-Chip and how it has been used in a recent study to detect sickle cell disease and amyotrophic lateral sclerosis (ALS).

Technology Networks recently spoke with Dr. Nick Downey, NGS collaborations lead at IDT, to learn more about the ways that NGS is being used as part of the response to the pandemic and gain insights into how and why this varies globally.

In this interview, Dr. Koh Meng Yong discusses the advantages of using lentiviral vectors and some of the applications they are enabling.